Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03766022
Other study ID # CTIL-0418-18-RMB
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 22, 2019
Est. completion date April 2024

Study information

Verified date April 2023
Source Rambam Health Care Campus
Contact Hadar Zigdon, DMD
Phone 9727772983
Email h_zigdon@rambam.health.gov.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Aim of this study randomized prospective clinical trial is to examine and compare periimplant tissue changes between heavy smokers and non-smokers at 12 months post loading using the alpha Bio Neo standard diameter implants with conical abutment.


Description:

Peri-implant marginal bone level is one of the most important references criteria to monitor peri-implant health.A radiographically measured marginal bone loss of up to 1.5 mm during the first year of loading, followed by a marginal bone loss of up to 0.2 mm for each succeeding year, is an acceptable criterion to determine implant success. Smoking has been implicated in many adverse systemic outcomes, including tooth loss, alveolar bone loss and dental implant failure. Platform switching, also known as platform shifting, is whenever an abutment is used that is smaller in diameter than the implant platform. Platform switching can help prevent crestal bone loss. The hypothesis of the present study is that the use of conical abutment might reduce marginal bone loss around dental implants in both smokers and non-smokers alike.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date April 2024
Est. primary completion date April 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 85 Years
Eligibility Inclusion Criteria: 1. Age between 20 - 85 years. 2. Written informed consent. 3. In need for a dental implant Adequate alveolar bone Intended to be restored with individual crowns. 4. Heavy smokers (20 Cig/d > 5years) or non / former smokers (> 5 years since cessation). Exclusion Criteria: 1. Active periodontal disease. 2. Systemic condition and medication that may affect soft and hard tissue. 3. healing Parafunctional occlusal scheme and habits. 4. Pregnancy or intention to become pregnant in the following twelve months. 5. Patient not willing or able to meet the study schedule. 6. Patient in need for simultaneous bone graft or GBR using a membrane barrier.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Neo dental implant Alpha Bio Tec. Ltd.
Neo dental implant is used to restore missing teeth

Locations

Country Name City State
Israel Rambam Hospital Haifa

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Other Implant stability Osstel measurements Immediatly after implant installation (day 0) and 4 months after implantation
Primary marginal bone loss Standardized periapical radiographs will be used to assess changes in radiographic bone height. 6 months and 18 months after implantation.
Secondary Implants probing depth (IPD) will be measured by inserting a probe to the gingival pocket at six sites around implant 4 months, 6 months and 16 months after implantation
Secondary Bleeding on probing will be measured by inserting a probe to the gingival pocket at six sites around each implant: Dichotomic measurments: Yes/No 4 months, 6 months and 16 months after implantation
Secondary Labial gingival recession will be measured using the incisal edge. occlusal plan as a fixed reference point. 4 months, 6 months and 16 months after implantation